Jonathan S. Batchelor[email protected]ISAuntMinnie.com RIS Radiology InsiderApril 23, 2006Nuclear MedicineC-11 topotecan PET shows promise for predicting therapeutic responsePET and PET/CT have demonstrated superiority in staging most cancers, depending on the radiopharmaceutical tracer used in the imaging study. The technology has also proved its strength in myocardial perfusion exams. The next frontier for the modality may be determining the efficacy of drug therapies for oncology patients, according to research presented at the 2006 Academy of Molecular Imaging (AMI) meeting in Orlando, FL.April 20, 2006Molecular ImagingAuntMinnie.com Molecular Imaging Radiology InsiderApril 16, 2006ISHIPAA compliance remains inconsistentTen years have come and gone since the passage of the Health Insurance Portability and Accountability Act (HIPAA), yet U.S. healthcare providers are still wrestling with HIPAA compliance. According to a survey conducted in January this year, a significant number of healthcare providers and payors report that they are noncompliant with segments of the HIPAA regulations.April 11, 2006Practice ManagementAuntMinnie.com Imaging Center Radiology InsiderApril 9, 2006CTMDCT during pregnancy requires caution, considerationPHOENIX - Multidetector CT has arguably become the primary diagnostic tool in U.S. emergency departments, but special care and consideration are necessary when using the modality with pregnant woman, according to a presentation at the 2006 Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR) meeting on Tuesday.April 4, 2006MRI3-tesla MR shows promise for abdominal, pelvic imagingPHOENIX - Three-tesla MRI offers improved signal-to-noise and contrast-to-noise ratios compared with 1.5-tesla for body imaging, according to a presentation at the 2006 Society of Computed Body Tomography and Magnetic Resonance (SCBT/MR) meeting. However, several issues such as cost, weight, safety, and modified imaging protocols may mitigate these advantages.April 3, 2006Nuclear MedicineLimiting scan range cuts dose, boosts throughput in melanoma PET/CTORLANDO, FL - The current PET/CT protocol of scanning all melanoma patients from the crown of the head to the soles of the feet, including dedicated brain studies, may be providing little clinical value and putting patients on the gantry longer than needed, according to a study from the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).March 29, 2006CTPET/CT shows virtual bronchoscopy potentialORLANDO, FL - Three-dimensional visualization with PET/CT may soon be expanded to virtual bronchoscopy, providing a new tool for diagnosis, treatment planning, and interventional guidance, according to a multidisciplinary group from Stanford University in California.March 29, 2006Molecular ImagingRising serum markers trigger first-line PET investigationORLANDO, FL - The post-therapy cancer protocol at many institutions is to watch and wait. If patients manifest elevated serum tumor markers such as S100 or carcinoembryonic antigen (CEA) during this follow-up period, conventional diagnostic methods call for the use of anatomic imaging first, then molecular imaging if necessary. A group in the Netherlands has flipped the imaging order, using PET as the primary imaging modality for occult tumors.March 28, 2006Previous PagePage 21 of 82Next PageTop StoriesInterventionalGAE reduces pain biomarkers in knee osteoarthritisGenicular artery embolization (GAE) significantly reduces key biomarkers that drive pain in patients with knee osteoarthritis.Residents/FellowsRace, ethnicity influence educational debt among radiology-bound MDsMRIMRI, CT findings correlate for assessing epicardial fat volumePractice ManagementImaging experts hope NSA enforcement bill delivers on accountabilityCTPET/CT identifies bone demineralization in breast cancer patients
